Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schade

Showing results (21-30 of 205) with videos related to

Pageof 21
Sort By:
Metabolism: Clinical and Experimental|May 1, 1974
Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in manR P Eaton, D S Schade
Endocrinology and Metabolism Clinics of North America|October 6, 1997
InsulinsM R Burge, D S Schade
The Journal of Clinical Endocrinology and Metabolism|January 1, 1980
The temporal relationship between endogenously secreted stress hormones and metabolic decompensation in diabetic manD S Schade, R P Eaton
Clinical and Experimental Pharmacology & Physiology|July 1, 1981
The ketotic ratio (KB/NEFA) in manD S Schade, R P Eaton
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 1, 1977
The effect of short term physiological elevations of plasma glucagon concentration on plasma triglyceride concentration in normal and diabetic manD S Schade, R P Eaton
Diabetes|November 1, 1975
Modulation of fatty acid metabolism by glucagon in man. III. Role of pharmacologic limitation of FFA availabilityD S Schade, R P Eaton
Diabetes|May 1, 1975
Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabeticsD S Schade, R P Eaton
Diabetes|January 1, 1982
Bactericidal properties of commercial U.S.P. formulated insulinD S Schade, R P Eaton
Hospital Practice (1995)|December 15, 1996
Diabetes mellitus: 2. Managing type II diseaseM R Burge, D S Schade
Diabetes|June 1, 1977
The controversy concerning counterregulatory hormone secretion. A hypothesis for the prevention of diabetic ketoacidosis?D S Schade, R P Eaton
Pageof 21

Showing results (21-30 of 205) with videos related to

Sort By:
Pageof 21
Metabolism: Clinical and Experimental|May 1, 1974
Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in manR P Eaton, D S Schade
Endocrinology and Metabolism Clinics of North America|October 6, 1997
InsulinsM R Burge, D S Schade
The Journal of Clinical Endocrinology and Metabolism|January 1, 1980
The temporal relationship between endogenously secreted stress hormones and metabolic decompensation in diabetic manD S Schade, R P Eaton
Clinical and Experimental Pharmacology & Physiology|July 1, 1981
The ketotic ratio (KB/NEFA) in manD S Schade, R P Eaton
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 1, 1977
The effect of short term physiological elevations of plasma glucagon concentration on plasma triglyceride concentration in normal and diabetic manD S Schade, R P Eaton
Diabetes|November 1, 1975
Modulation of fatty acid metabolism by glucagon in man. III. Role of pharmacologic limitation of FFA availabilityD S Schade, R P Eaton
Diabetes|May 1, 1975
Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabeticsD S Schade, R P Eaton
Diabetes|January 1, 1982
Bactericidal properties of commercial U.S.P. formulated insulinD S Schade, R P Eaton
Hospital Practice (1995)|December 15, 1996
Diabetes mellitus: 2. Managing type II diseaseM R Burge, D S Schade
Diabetes|June 1, 1977
The controversy concerning counterregulatory hormone secretion. A hypothesis for the prevention of diabetic ketoacidosis?D S Schade, R P Eaton
Pageof 21